Related Experiment Video
Updated: May 13, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
[Genetic polymorphism affects the clinical effects of opioids after surgery]
Andreas Frydshou1, Egon Godthåb Hansen, Ismail Gögenur
1Anæstesiologisk Afdeling I, Herlev Hospital, Denmark. andreas.fryd@get2net.dk
Abstract:
Post-operative pain-management (PPM) should first of all be decided by the specific surgical procedure in each case, but it also seems that genetic polymorphism affects the clinical effects of the pharmacological treatment. In this article we summarize the existing evidence of the hypothesis that the A118G-variant of the µ-opioidreceptor-gene OPRM1 affects clinical response to opioids after gynaecological and abdominal surgery. If the genetic profile of each patient becomes easier accessible in the future, PPM might be planned accordingly to surgical procedure as well as to genetic profile to avoid post-operative pain and pharmacological adverse effects.
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Pharmacogenetics of Drug Metabolism: Overview
Opioid Receptors: Overview